#strensiq

Strensiq/Asfotase Alfa Side effects, Cost, Dosage for Hypophosphatasia. Strensiq is marketed by Alexion pharmaceuticals.

Strensiq is approved by FDA on 23rd October 2015.Its active ingredient is asfotase alfa.Strensiq asfotase alfa is used as the initially endorsed treatment for perinatal, infantile and juvenile onset hypophosphatasia (HPP). HPP is an uncommon, hereditary, progressive, metabolic…